Atul Saran, a senior vice president of the biotechnology company MedImmune, planned to “churn through” eight to 12 meetings a day during the BIO convention in Boston, which ends its four-day run on Thursday. Michal Preminger, executive director of Harvard University’s Office of Technology Development, had 70 BIO meetings entered into the scheduling software on her Apple iPad. And Christine Menjoz, project director of strategy and business development at Sanofi, is meeting only with new companies at BIO, so her pace has been just six or seven meetings a day.
The sprawling Biotechnology Industry Organization conference, held at the Boston Convention & Exhibition Center, features high-profile keynote addresses, dozens of industry panels and breakout sessions, nightly networking soirees, and hundreds of booths and pavilions in the exhibition hall. But the main events for many attendees are dozens and dozens of “partner meetings” with other companies and institutions.